1 |
Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins
| 1件: HB-adMSCs HB-adMSCs | - | - | - | 5件: 2 2, 6, 13, 14, 46 |
2 |
Batoclimab
| 1件: Batoclimab Batoclimab | 1件: D11983
D11983
| 1件: FCGRT FCGRT 💬 | - | 2件: 11 11, 14 |
3 |
Carmustine
| 1件: Carmustine Carmustine | 1件: D00254
D00254
| - | - | 5件: 11 11, 13, 14, 28, 60 |
4 |
Chloride ion
| 1件: Chloride Chloride | - | - | - | 28件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 |
5 |
Chlorpheniramine
| 1件: Clorfenamina Clorfenamina | 1件: D07398
D07398
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 14 14 |
6 |
Clostridium tetani toxoid antigen (formaldehyde inactivated)
| 4件: Boostrix Boostrix; Nimenrix; TETANUS TOXOID; Tetanus toxoid adsorbed | - | - | - | 4件: 13 13, 14, 46, 50 |
7 |
Corticotropin
| 5件: ACTH ACTH; Acthar; Adrenocorticotropic hormone; Corticotrophin; Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 12件: 2 2, 13, 14, 46, 49, 50, 66, 75, 81, 84, 145, 222 |
8 |
Cyclophosphamide
| 6件: Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan | 2件: D00287
D00287
,
D07760
| - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
9 |
Cytarabine
| 1件: Cytarabine Cytarabine | 1件: D00168
D00168
| - | - | 7件: 11 11, 13, 14, 25, 49, 60, 65 |
10 |
Dalfampridine
| 7件: 4-Aminopyridine 4-Aminopyridine; 4-AP; AMPYRA; Dalfampridine; FAMPRIDINA; FAMPRIDINE; Fampyra | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 5件: 3 3, 4, 6, 13, 14 |
11 |
Dexamethasone
| 5件: Decadron Decadron; Dexametasona; Dexamethasone; DEXAMETHASONE SODIUM PHOSPHATE; Maxidex | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
12 |
Eculizumab
| 2件: Eculizumab Eculizumab; SOLIRIS | 1件: D03940
D03940
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 11 11, 13, 14, 61, 62, 109, 222 |
13 |
Efgartigimod alfa
| 1件: EFGARTIGIMOD ALFA EFGARTIGIMOD ALFA | 1件: D11876
D11876
| 1件: FCGRT FCGRT 💬 | - | 6件: 11 11, 14, 35, 53, 63, 162 |
14 |
Etoposide
| 1件: Etoposide Etoposide | 1件: D00125
D00125
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 11件: 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
15 |
Fibrinogen human
| 3件: Fibrinogen Fibrinogen; Fibrinogen concentrate; HUMAN FIBRINOGEN | - | - | - | 2件: 14 14, 65 |
16 |
Fingolimod
| 3件: FINGOLIMOD FINGOLIMOD; FINGOLIMOD HYDROCHLORIDE; GILENYA | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 14, 156 |
17 |
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
| 2件: Act-HiB Act-HiB; ActHIB | - | - | - | 5件: 14 14, 61, 62, 66, 222 |
18 |
Human immunoglobulin G
| 19件: Bivigam Bivigam; CUTAQUIG; CUVITRU; GAMMAGARD LIQUID; Gammaplex; GAMUNEX-C; Hizentra; Human immunoglobulin G; Human normal immunoglobulin; HyQvia; Immune globulin; Immunoglobulin; IMMUNOGLOBULIN G; IVIG; KIOVIG; Octagam; PANZYGA; PRIVIGEN; Vivaglobin | - | - | - | 10件: 11 11, 13, 14, 17, 43, 45, 50, 51, 63, 65 |
19 |
Hyaluronidase
| 2件: Hyaluronidase Hyaluronidase; Hyaluronoglucosaminidase | 3件: D04455
D04455
,
D04456
,
D06604
| - | - | 5件: 14 14, 28, 51, 65, 331 |
20 |
Hyaluronidase (human recombinant)
| 3件: Hyaluronidase Hyaluronidase; HYQVIA; Recombinant human hyaluronidase | - | - | - | 3件: 14 14, 28, 65 |
21 |
Lipoic acid
| 3件: Alpha Lipoic Acid Alpha Lipoic Acid; ALPHA-LIPOIC ACID; Lipoic acid | - | - | - | 5件: 2 2, 5, 13, 14, 20 |
22 |
Melphalan
| 3件: Alkeran Alkeran; Melphalan; Melphalan Hydrochloride | 1件: D00369
D00369
| - | - | 15件: 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 |
23 |
Methylprednisolone
| 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
24 |
Nipocalimab
| 1件: Nipocalimab Nipocalimab | 1件: D11666
D11666
| 1件: FCGRT FCGRT 💬 | - | 6件: 11 11, 14, 46, 49, 53, 61 |
25 |
Prednisolone
| 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
26 |
Prednisone
| 3件: Prednisona Prednisona; PREDNISONE; RAYOS | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
27 |
Rituximab
| 6件: MabThera MabThera; Rituxan; RITUXIMAB; Rixathon; Ruxience; Truxima | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
28 |
Rozanolixizumab
| 1件: ROZANOLIXIZUMAB ROZANOLIXIZUMAB | 1件: D12182
D12182
| 1件: FCGRT FCGRT 💬 | - | 3件: 11 11, 14, 63 |
29 |
Sodium chloride
| 6件: Lactated Ringers Lactated Ringers; Natriumchlorid; REBIF; Saline; Sodium chloride; Sporanox | 1件: D02056
D02056
| - | - | 20件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 |
30 |
Streptococcus pneumoniae type 1 capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
31 |
Streptococcus pneumoniae type 14 capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
32 |
Streptococcus pneumoniae type 18c capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
33 |
Streptococcus pneumoniae type 19a capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
34 |
Streptococcus pneumoniae type 19f capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
35 |
Streptococcus pneumoniae type 23f capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
36 |
Streptococcus pneumoniae type 3 capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
37 |
Streptococcus pneumoniae type 4 capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
38 |
Streptococcus pneumoniae type 5 capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
39 |
Streptococcus pneumoniae type 6b capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
40 |
Streptococcus pneumoniae type 7f capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |
41 |
Streptococcus pneumoniae type 9v capsular polysaccharide antigen
| 2件: Pneumovax 23 Pneumovax 23; Prevenar 13 | - | - | - | 6件: 13 13, 14, 46, 50, 96, 222 |